Study Refutes Prion Theory of Alpha-Synuclein Aggregates in Parkinson’s Disease

Study Refutes Prion Theory of Alpha-Synuclein Aggregates in Parkinson’s Disease

A new study from the German Center for Neurodegenerative Diseases, published in the journal BRAIN, sheds new light on the processes leading to aggregation of the protein αlpha-synuclein in the brain of patients with Parkinson’s disease (PD). It has been proposed that the aggregates propagate in a fashion similar to prions, but the new study refutes the prion theory.

The protein α-synuclein often starts aggregating inside neurons of the lowest part of the brainstem and spreads upward from there. To study how this protein moves in the brain, the research team transferred a human α-synuclein gene into the brainstem neurons of mice with the help of a viral vector.

The team noticed that following the introduction of the human α-synuclein, the cells began expressing high levels of the protein, which accumulated inside the cells. Over the following 12 weeks, the team tracked the spread of the human α-synuclein, noticing it moved in a similar way to that observed in Parkinson’s patients; upward and toward the front of the brain.

The protein spread through anatomical pathways, and the researchers observed it jumping between two neurons via a synapse – the chemical connection between neurons. They also saw that once the protein entered a neuron, the cell became damaged.

To test the prion theory, researchers compared the spread of α-synuclein in animals that expressed the mouse form of the protein and those expressing only the introduced human form. Prions are spread by inducing a change in the three-dimensional structure of nearby proteins. If α-synuclein spread like prions, the spread would be slower, and the functional effects of the protein aggregates would not be as severe in the mice lacking mouse α-synuclein, since the introduced α-synuclein would not have other α-synuclein proteins to corrupt.

Instead, the team observed the opposite – a more rapid spread in mice lacking their own α-synuclein.

Pofessor Donato Di Monte, who led the study, stated in a press release,”We believe that these findings bear a number of important implications for disease pathogenesis. Not only can we conclude that long-distance diffusion of alpha-synuclein does not necessarily require the generation of prion-like species, our data also reveal that spreading and pathology can be triggered by simple overexpression of the protein and are mediated, at least initially, by monomeric and/or oligomeric alpha-synuclein.”

“There is absolutely no indication that Parkinson’s could be a contagious disease,” Di Monte said. “In fact, an important contribution of our new study is that it emphasizes how critical aspects of Parkinson’s disease pathogenesis, such as neuron-to-neuron alpha-synuclein transmission and protein aggregation, can be explained by mechanisms that are not prion-like.”

Tagged , , , .

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

Leave a Comment

Your email address will not be published. Required fields are marked *